nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Swelling—Carmustine—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Aztreonam—Haemoglobin—Fludarabine—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Aztreonam—Haemorrhage—Fludarabine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Aztreonam—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Aztreonam—Swelling—Mitoxantrone—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Aztreonam—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Aztreonam—Diplopia—Carmustine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Aztreonam—Anaemia—Teniposide—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Aztreonam—Bronchospasm—Bleomycin—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Aztreonam—Pancytopenia—Bleomycin—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Aztreonam—Chest pain—Teniposide—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Aztreonam—Confusional state—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Aztreonam—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Aztreonam—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Aztreonam—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Aztreonam—Anaemia—Fludarabine—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Aztreonam—Stomatitis—Bleomycin—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Aztreonam—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Aztreonam—Malaise—Fludarabine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Aztreonam—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00423	0.00423	CcSEcCtD
Aztreonam—Pruritus—Mechlorethamine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Aztreonam—Cough—Fludarabine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Pancytopenia—Carmustine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Aztreonam—Hypotension—Teniposide—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Aztreonam—Convulsion—Fludarabine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Aztreonam—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Aztreonam—Neutropenia—Carmustine—lymphatic system cancer	0.00404	0.00404	CcSEcCtD
Aztreonam—Myalgia—Fludarabine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Aztreonam—Haemoglobin—Bleomycin—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Aztreonam—Haemorrhage—Bleomycin—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Aztreonam—Discomfort—Fludarabine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Aztreonam—Pancytopenia—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Aztreonam—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Aztreonam—Dyspnoea—Teniposide—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Aztreonam—Petechiae—Methotrexate—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Aztreonam—Confusional state—Fludarabine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Aztreonam—Neutropenia—Vincristine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Aztreonam—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Aztreonam—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Aztreonam—Vomiting—Mechlorethamine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Aztreonam—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Aztreonam—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Aztreonam—Stomatitis—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Aztreonam—Rash—Mechlorethamine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Aztreonam—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Aztreonam—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Aztreonam—Flushing—Bleomycin—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Aztreonam—Feeling abnormal—Teniposide—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Aztreonam—Stomatitis—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Aztreonam—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Aztreonam—Nausea—Mechlorethamine—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Aztreonam—Jaundice—Mitoxantrone—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Aztreonam—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Aztreonam—Haemoglobin—Carmustine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Aztreonam—Urticaria—Teniposide—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Aztreonam—Haemorrhage—Carmustine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Aztreonam—Abdominal pain—Teniposide—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Aztreonam—Body temperature increased—Teniposide—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Aztreonam—Erythema—Bleomycin—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Paraesthesia—Fludarabine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Dyspnoea—Fludarabine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Aztreonam—Pain—Fludarabine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Aztreonam—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Aztreonam—Hypersensitivity—Teniposide—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Aztreonam—Flushing—Carmustine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Aztreonam—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Aztreonam—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Aztreonam—Anaemia—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Aztreonam—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Aztreonam—Asthenia—Teniposide—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Aztreonam—Malaise—Bleomycin—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Aztreonam—Pruritus—Teniposide—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Aztreonam—Body temperature increased—Fludarabine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Aztreonam—Vaginal infection—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Aztreonam—Erythema—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Aztreonam—Cough—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Aztreonam—Diarrhoea—Teniposide—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Aztreonam—Chest pain—Bleomycin—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Aztreonam—Myalgia—Bleomycin—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Aztreonam—Discomfort—Bleomycin—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Aztreonam—Confusional state—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Aztreonam—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Aztreonam—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Aztreonam—Erythema—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Aztreonam—Anaemia—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Vomiting—Teniposide—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Aztreonam—Asthenia—Fludarabine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Aztreonam—Rash—Teniposide—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Aztreonam—Dermatitis—Teniposide—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Aztreonam—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Aztreonam—Headache—Teniposide—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Aztreonam—Pruritus—Fludarabine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Aztreonam—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Anaemia—Vincristine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Aztreonam—Hypotension—Bleomycin—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Aztreonam—Diarrhoea—Fludarabine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Aztreonam—Convulsion—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Aztreonam—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Aztreonam—Nausea—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Aztreonam—Anaemia—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Vertigo—Vincristine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Aztreonam—Chest pain—Carmustine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Aztreonam—Myalgia—Carmustine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Aztreonam—Paraesthesia—Bleomycin—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Aztreonam—Malaise—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Aztreonam—Dyspnoea—Bleomycin—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Aztreonam—Convulsion—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Aztreonam—Confusional state—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Aztreonam—Myalgia—Vincristine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Aztreonam—Cough—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Aztreonam—Vomiting—Fludarabine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Aztreonam—Convulsion—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Aztreonam—Rash—Fludarabine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Aztreonam—Dermatitis—Fludarabine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Aztreonam—Pain—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Aztreonam—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Aztreonam—Headache—Fludarabine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Aztreonam—Chest pain—Mitoxantrone—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Aztreonam—Myalgia—Mitoxantrone—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Aztreonam—Discomfort—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Aztreonam—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Aztreonam—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Aztreonam—Confusional state—Mitoxantrone—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Aztreonam—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Aztreonam—Hypotension—Carmustine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Aztreonam—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Aztreonam—Nausea—Fludarabine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Aztreonam—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Aztreonam—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Aztreonam—Urticaria—Bleomycin—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Aztreonam—Body temperature increased—Bleomycin—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Aztreonam—Insomnia—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Aztreonam—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Aztreonam—Paraesthesia—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Aztreonam—Hypotension—Vincristine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Aztreonam—Dyspnoea—Carmustine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Aztreonam—Hypotension—Mitoxantrone—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Aztreonam—Insomnia—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Aztreonam—Paraesthesia—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Pain—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Aztreonam—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Aztreonam—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Aztreonam—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Aztreonam—Feeling abnormal—Carmustine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Aztreonam—Asthenia—Bleomycin—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Aztreonam—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Aztreonam—Pain—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Aztreonam—Pruritus—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Aztreonam—Pain—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Aztreonam—Body temperature increased—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Aztreonam—Abdominal pain—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Aztreonam—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Aztreonam—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Aztreonam—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Aztreonam—Abdominal pain—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Aztreonam—Body temperature increased—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Aztreonam—Urticaria—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Hypersensitivity—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Vomiting—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Aztreonam—Rash—Bleomycin—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Aztreonam—Dermatitis—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Aztreonam—Asthenia—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Hypersensitivity—Vincristine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Asthenia—Vincristine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Diarrhoea—Carmustine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Nausea—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Asthenia—Mitoxantrone—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Dizziness—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Aztreonam—Diarrhoea—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Aztreonam—Vomiting—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Aztreonam—Dizziness—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Rash—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Dermatitis—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Headache—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Aztreonam—Vomiting—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Aztreonam—Rash—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Dermatitis—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Headache—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Aztreonam—Nausea—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Vomiting—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Aztreonam—Rash—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Headache—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Aztreonam—Erythema—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Aztreonam—Nausea—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Aztreonam—Nausea—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Malaise—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Aztreonam—Cough—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Pain—Methotrexate—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—lymphatic system cancer	0.000779	0.000779	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—lymphatic system cancer	0.000753	0.000753	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Aztreonam—Rash—Methotrexate—lymphatic system cancer	0.000718	0.000718	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—lymphatic system cancer	0.000717	0.000717	CcSEcCtD
Aztreonam—Headache—Methotrexate—lymphatic system cancer	0.000713	0.000713	CcSEcCtD
Aztreonam—Nausea—Methotrexate—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
